.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Covington
Chubb
Federal Trade Commission
Queensland Health
Cipla
Johnson and Johnson
US Army
Cantor Fitzgerald

Generated: December 16, 2017

DrugPatentWatch Database Preview

Sibutramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for sibutramine hydrochloride and what is the scope of sibutramine hydrochloride freedom to operate?

Sibutramine hydrochloride
is the generic ingredient in one branded drug marketed by Abbott and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for sibutramine hydrochloride.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-002Nov 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-003Nov 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-001Nov 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sibutramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-003Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-001Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-003Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-003Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-002Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-002Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-002Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-001Nov 22, 1997► Subscribe► Subscribe
AbbottMERIDIAsibutramine hydrochlorideCAPSULE;ORAL020632-001Nov 22, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Medtronic
McKesson
Argus Health
QuintilesIMS
US Department of Justice
Queensland Health
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot